ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RXRX Recursion Pharmaceuticals Inc

8.12
0.28 (3.57%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.53M5.33M7.67M13.16M13.68M12.13M11.02M10.53M
Operating Income -64.96M-55.98M-66.19M-62.57M-60.98M-69.87M-81.72M-99.55M
Pre Tax Income -64.93M-55.98M-65.56M-60.45M-57.49M-65.33M-76.73M-93.02M
Net Income -64.93M-55.98M-65.56M-60.45M-57.49M-65.33M-76.73M-93.02M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -64.96M-56.05M-66.2M-62.34M-61.16M-69.97M-81.66M-98.01M
EBITDA -62.38M-53.21M-63.41M-59.75M-54.77M-64.91M-76.23M-91.95M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.32M3.96M10.18M39.84M44.58M
Operating Income -62.44M-84.38M-182.78M-245.73M-350.06M
Pre Tax Income -61.88M-87.01M-186.48M-239.48M-332.13M
Net Income -61.88M-87.01M-186.48M-239.48M-328.07M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -4.29-5.849-0.548-0.703-0.76
EBIT -62.43M-84.87M-182.77M-245.68M-351.15M
EBITDA -58.9M-79.3M-173.67M-231.14M-324.47M

Your Recent History

Delayed Upgrade Clock